Abstract: The invention relates to a heating structure (30) which is intended in particular to be installed inside a passenger compartment of a vehicle, the heating structure (30) comprising at least one resistive layer arranged to release heat when an electric current passes through this layer (36), this panel further comprising art electrode array comprising a plurality of contact electrodes (34) arranged to be in electrical contact with the resistive layer in order to Sallow electric current to flow through this resistive layer.

Abstract: A radiant panel (1) intended to be installed inside a vehicle (80) passenger compartment (3), in particular a motor vehicle passenger compartment, the radiant panel (1) comprising at least one array of electrodes with at least two primary electrodes of different polarities, the array of electrodes being arranged such that at least two primary electrodes of different polarities each define at least one spiral winding around one another.

Abstract: A radiant panel (3) intended to be installed inside a passenger compartment (1) of a vehicle (2), a motor vehicle for example, is disclosed. The radiant panel (3) includes a dissipative region (10) arranged to generate heat by Joule heating and at least one functional component (17) arranged to perform at least one function other than generating heat by Joule heating in the dissipative region (10).

Abstract: The invention relates to novel silane compounds corresponding to the formula (I) below: A-E-X?? (I) in which: X represents a silyl group capable of creating a covalent bond after reaction with the hydroxyl or hydride functional groups of a support; E represents an organic spacer group; A represents a group chosen from the groups of formulae below: in which: Z1 to Z5 independently represent a hydrogen atom or a halogen atom; Z6 and Z7 represent a group for protecting the phosphonic acid functional group, a hydrogen atom or a monovalent cation; Z8 to Z12 independently represent a group for protecting the carboxylic acid functional group, a hydrogen atom or a monovalent cation; and Z13 represents an imidazole, N-hydroxysuccinimide, nitrophenyl, pentafluorophenyl or acid anhydride group. Use of these silane compounds for functionalizing solid supports and for immobilizing biological molecules on these supports.

Abstract: The invention relates to novel silane compounds corresponding to the following formula (I): A-E-X??(I) in which: X represents a silylated group which makes possible the covalent attachment of the silane compound to the hydroxyl or hydride functional groups of a support; E represents an organic spacer group; A represents a group capable of releasing an —OH functional group by acid hydrolysis, the said —OH functional group, after the said hydrolysis, being covalently bonded to E. Use of these silane compounds for functionalizing solid supports and for immobilizing biological molecules on these supports.

Abstract: The present invention relates to a new homodimeric form of recombinant PlGF-1, to a process for its preparation and to compositions containing it.

Abstract: The subject matter of the invention is a method of surface modification of a pigment or of a composite pigment comprising at least a metal oxide, a metal complex or a derivative thereof, and the use of these pigments or composite pigments thus obtained for cosmetics, paint or inks.

Abstract: Antibody or fragment thereof, which specifically binds to folate receptor-alpha (FR?), wherein said antibody or fragment thereof comprises a light chain whose variable region comprises at least one of the following amino acid sequences: —RASESVSFLGINLIH (SEQ ID NO: 3), —QASNKDT (SEQ ID NO: 4), —LQSKNFPPYT (SEQ ID NO: 5), and wherein the constant region of said light chain is a kappa constant region.

Abstract: The present invention relates to a method of producing a recombinant protein comprising using a selection method other than antibiotics. In particular, it relates to a stable host/vector system based on the pyrC gene complementation designed to produce high level of heterologous recombinant protein in Escherichia coli. The expression system of the present invention allows rapid selection of plasmid containing cells during the cloning phases and lead to high protein expression during fermentation. This system has a strong selective efficiency, especially during the induction phase, leading to the selection of an almost homogeneous and stable plasmid bearing cell population. Moreover the productivity of the culture is to a large extent better than the one based on antibiotic resistance. This elevated vector stability combined with its high productivity fulfils the requirements for heterologous protein production in Escherichia coli to an industrial level.

Abstract: The present invention relates to a new homodimeric form of recombinant PlGF-1, to a process for its preparation and to compositions containing it.

Abstract: A device (6) to sample molecules of biological interest is described. The device (6) includes capture zones (10) whose developed surface area is much greater than the surface so that sampling by contact allows a sufficient quantity of molecules to be obtained to achieve reliable analysis, whilst being sized so that the device (6) is neither invasive nor aggressive. In particular, the device comprises tiered capture zones (10) located on a support (12) fabricated using microtechnology techniques; the capture zones (10) may advantageously be functionalised.

Abstract: The invention relates to novel silane compounds corresponding to the following formula (I): in which R1 can represent a methyl group, R2 and R3 can represent a hydrogen atom, A can represent —O—, E can represent an alkylene group, X can represent a methoxysilane group, Z can represent a simple bond and Y can represent an —N2 or —N—NH2 group. Use of these silane compounds to functionalize solid supports and to immobilize biological molecules on these supports.

Abstract: The present invention relates to a method of producing a recombinant protein comprising using a selection method other than antibiotics. In particular, it relates to a stable host/vector system based on the pyrC gene complementation designed to produce high level of heterologous recombinant protein in Escherichia coli. The expression system of the present invention allows rapid selection of plasmid containing cells during the cloning phases and lead to high protein expression during fermentation. This system has a strong selective efficiency, especially during the induction phase, leading to the selection of an almost homogeneous and stable plasmid bearing cell population. Moreover the productivity of the culture is to a large extent better than the one based on antibiotic resistance. This elevated vector stability combined with its high productivity fulfils the requirements for heterologous protein production in Escherichia coli to an industrial level.

Abstract: Antibody or fragment thereof, which specifically binds to folate receptor-alpha (FR?), wherein said antibody or fragment thereof comprises a light chain whose variable region comprises at least one of the following amino acid sequences: RASESVSFLGINLIH, (SEQ ID NO: 3) QASNKDT, (SEQ ID NO: 4) LQSKNFPPYT, (SEQ ID NO: 5) and wherein the constant region of said light chain is a kappa constant region.

Abstract: A device (6) to sample molecules of biological interest is described. The device (6) includes capture zones (10) whose developed surface area is much greater than the surface so that sampling by contact allows a sufficient quantity of molecules to be obtained to achieve reliable analysis, whilst being sized so that the device (6) is neither invasive nor aggressive. In particular, the device comprises tiered capture zones (10) located on a support (12) fabricated using microtechnology techniques; the capture zones (10) may advantageously be functionalised.

Abstract: A microtechnological device (6) for sampling cells on or in a tissue or other element of the body. It comprises a support (12) having at least one surface of interest (14) on which is present at least one recovery zone (10) comprised of a bottom wall (22) equipped with a plurality of protuberances (24). Preferably, the microtechnological device comprises at least one recovery zone covered with a coating that has the power to attract the cells to be sampled.

Abstract: The invention relates to novel silane compounds corresponding to the following formula (I): in which R1 can represent a methyl group, R2 and R3 can represent a hydrogen atom, A can represent —O—, E can represent an alkylene group, X can represent a methoxysilane group, Z can represent a simple bond and Y can represent an —N2 or —N—NH2 group. Use of these silane compounds to functionalize solid supports and to immobilize biological molecules on these supports.

Abstract: The invention relates to novel silane compounds corresponding to the formula (I) below: A-E-X??(I) in which: X represents a silyl group capable of creating a covalent bond after reaction with the hydroxyl or hydride functional groups of a support; E represents an organic spacer group; A represents a group chosen from the groups of formulae below: in which: Z1 to Z5 independently represent a hydrogen atom or a halogen atom; Z6 and Z7 represent a group for protecting the phosphonic acid functional group, a hydrogen atom or a monovalent cation; Z8 to Z12 independently represent a group for protecting the carboxylic acid functional group, a hydrogen atom or a monovalent cation; and Z13 represents an imidazole, N-hydroxysuccinimide, nitrophenyl, pentafluorophenyl or acid anhydride group. Use of these silane compounds for functionalizing solid supports and for immobilizing biological molecules on these supports.

Abstract: The invention relates to novel silane compounds corresponding to the following formula (I): A-E-X??(I) in which: X represents a silylated group which makes possible the covalent attachment of the silane compound to the hydroxyl or hydride functional groups of a support; E represents an organic spacer group; A represents a group capable of releasing an —OH functional group by acid hydrolysis, the said —OH functional group, after the said hydrolysis, being covalently bonded to E. Use of these silane compounds for functionalizing solid supports and for immobilizing biological molecules on these supports.

Abstract: The invention relates to ?-silanyl n-alkanal compounds, method for production and use thereof in the fuctionalization of solid supports, solid supports functionalized by the compounds and the use of solid supports thus functionalized for the immobilization and/or synthesis of biological molecules of interest.